GJB2 MUTATIONS IN NON SYNDROMIC HEARING LOSS IN THE REPUBLIC OF MACEDONIA
Sukarova Stefanovska E1, Momirovska, A2,3, Cakar M4, Efremov GD1,*
*Corresponding Author: Georgi D. Efremov, Research Center for Genetic Engineering and Biotechnology, Macedonian Academy of Sciences and Arts, Blv. Krste Misirkov 2, 1000 Skopje, R. Macedonia; Tel.: +389-2-32-35-411; fax: +389-2-31-15-434; E-mail: gde@manu.edu.mk
page: 11

MATERIALS AND METHODS

There are approximately 6,000 persons with hearing loss or hearing impairment in Macedonia. Patients with hearing impairment have been ascer­tained through two regional otorhinolaryngology centers: Audiology Center, Clinic for Othorinolar-yngology, Medical faculty, Skopje and Association of Deaf and Hard of Hearing, Skopje, R. Mace­donia. We performed molecular analyses of the GJB2 gene on DNA samples from 80 individuals with non syndromic hearing loss (NSHL) belong­ing to 33 affected, unrelated families. Twenty-three families were of Macedonian, six of Albanian, one Turkish and three of Gypsy origin. After informed consent was obtained and examination of complete medical histories was made, the family inheritance and audiological status were ascertained. DNA was isolated from peripheral white blood cells using a phenol/chloroform extraction, ethanol precipitation method [8].

The 35delG mutation was identified by the method described by Storm etal. [9], in which poly­merase chain reaction (PCR) amplifications were performed with two sets of primers: GJB1: 5'-GTG AGG TTG TGT AAG AGT TG-3'; GJB2: 5'-CTG GTG GAG TGT TTG TTC CCA-3'; and as con­trol sequence: GJB7 5'-CCA GGC TGC AAG AAC GTG TGC-3' and GJB9: 5'-CTC ATG TCT CCG GTA GGC CAC-3' under standard PCR conditions. The PCR products were digested with BszYI (Boeh-ringer, Mannheim, Germany) and analyzed by 2% agarose gel electrophoresis (Figure 1A).

For other aberrations in the GJB2 gene, the single strand conformation polymorphism (SSCP) method was used. Amplification of a 286 bp frag­ment belonging to the 5' end of the exon 2 coding sequence was performed using the following prim­ers: GJB5 5'-TCT TTC CAG AGC AAA CCG C-3' and GJB8 5'-GAC ACG AAG ATC AGC TGC AGG-3', while a 270 bp fragment belonging to the 3' end of the GJB2 gene, was amplified using prim­ers: GJB10 5'-GCA GCA TCT TCT TCC GGG T-3' and GJB6 5'-GGG CAA TGC GTT AAA CTG GC-3'. The SSCP was performed on the Bio-Rad DeCode System (Bio-Rad Laboratories, Hercules, CA, USA). The PCR products were loaded onto a non denaturing 12% acrylamide/Bisacrylamide (39:1) gel. After electrophoresis, the PCR frag­ments were visualized with silver staining of the
gel.

To identify the nucleotide substitutions respon­sible for altered the electrophoretic mobility de­tected by SSCP analysis, the PCR fragments were sequenced by BigDye sequencing kit v3.1 (PE Ap­plied Biosystems, Foster City, CA, USA), accord­ing to the manufacturer's instructions and separated on an Applied Biosystems 310 Genetic analyzer.

The presence of the deletion delD13S1830 en­compassing part of the GJB6 gene was analyzed by use of three primers to simultaneously amplify the breakpoint-containing fragment and the normal GJB2 allele [10]. The primers used were: GJB6-1F 5'-AGT GAT CCA TCT GCC TCA GC-3'; GJB6-2RN 5'-GTC TGT GCT CTC TCT TTG ATC TC-3' and GJB6-3RD 5'-GGA AGG TGT GGA TCA CAG TC-3', under cycling conditions of initial denaturation of 10 min. at 95°C, followed by 30 cycles of 1 min. at 94°C, 1 min. at 60°C and 1 min. at 72°C in the Applied Biosystems 2720 thermal-cycler. The PCR fragments were analyzed by 1.5% agarose gel electrophoresis. The presence of a 478 bp fragment indicates the presence of the 342 kb deletion (Primers GJB6-1F and GJB6-3RD), while the presence of a 650 bp fragment indicates the nor­mal allele (primers GJB6-1F and GJB6-2RN).




Number 27
VOL. 27 (2), 2024
Number 27
VOL. 27 (1), 2024
Number 26
Number 26 VOL. 26(2), 2023 All in one
Number 26
VOL. 26(2), 2023
Number 26
VOL. 26, 2023 Supplement
Number 26
VOL. 26(1), 2023
Number 25
VOL. 25(2), 2022
Number 25
VOL. 25 (1), 2022
Number 24
VOL. 24(2), 2021
Number 24
VOL. 24(1), 2021
Number 23
VOL. 23(2), 2020
Number 22
VOL. 22(2), 2019
Number 22
VOL. 22(1), 2019
Number 22
VOL. 22, 2019 Supplement
Number 21
VOL. 21(2), 2018
Number 21
VOL. 21 (1), 2018
Number 21
VOL. 21, 2018 Supplement
Number 20
VOL. 20 (2), 2017
Number 20
VOL. 20 (1), 2017
Number 19
VOL. 19 (2), 2016
Number 19
VOL. 19 (1), 2016
Number 18
VOL. 18 (2), 2015
Number 18
VOL. 18 (1), 2015
Number 17
VOL. 17 (2), 2014
Number 17
VOL. 17 (1), 2014
Number 16
VOL. 16 (2), 2013
Number 16
VOL. 16 (1), 2013
Number 15
VOL. 15 (2), 2012
Number 15
VOL. 15, 2012 Supplement
Number 15
Vol. 15 (1), 2012
Number 14
14 - Vol. 14 (2), 2011
Number 14
The 9th Balkan Congress of Medical Genetics
Number 14
14 - Vol. 14 (1), 2011
Number 13
Vol. 13 (2), 2010
Number 13
Vol.13 (1), 2010
Number 12
Vol.12 (2), 2009
Number 12
Vol.12 (1), 2009
Number 11
Vol.11 (2),2008
Number 11
Vol.11 (1),2008
Number 10
Vol.10 (2), 2007
Number 10
10 (1),2007
Number 9
1&2, 2006
Number 9
3&4, 2006
Number 8
1&2, 2005
Number 8
3&4, 2004
Number 7
1&2, 2004
Number 6
3&4, 2003
Number 6
1&2, 2003
Number 5
3&4, 2002
Number 5
1&2, 2002
Number 4
Vol.3 (4), 2000
Number 4
Vol.2 (4), 1999
Number 4
Vol.1 (4), 1998
Number 4
3&4, 2001
Number 4
1&2, 2001
Number 3
Vol.3 (3), 2000
Number 3
Vol.2 (3), 1999
Number 3
Vol.1 (3), 1998
Number 2
Vol.3(2), 2000
Number 2
Vol.1 (2), 1998
Number 2
Vol.2 (2), 1999
Number 1
Vol.3 (1), 2000
Number 1
Vol.2 (1), 1999
Number 1
Vol.1 (1), 1998

 

 


 About the journal ::: Editorial ::: Subscription ::: Information for authors ::: Contact
 Copyright © Balkan Journal of Medical Genetics 2006